These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 12080331)

  • 1. Computer-aided design of a PDZ domain to recognize new target sequences.
    Reina J; Lacroix E; Hobson SD; Fernandez-Ballester G; Rybin V; Schwab MS; Serrano L; Gonzalez C
    Nat Struct Biol; 2002 Aug; 9(8):621-7. PubMed ID: 12080331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of PDZ domain specificity, prediction of ligand affinity and rational design of super-binding peptides.
    Wiedemann U; Boisguerin P; Leben R; Leitner D; Krause G; Moelling K; Volkmer-Engert R; Oschkinat H
    J Mol Biol; 2004 Oct; 343(3):703-18. PubMed ID: 15465056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of the second PDZ domain of SAP97 in complex with a GluR-A C-terminal peptide.
    von Ossowski I; Oksanen E; von Ossowski L; Cai C; Sundberg M; Goldman A; Keinänen K
    FEBS J; 2006 Nov; 273(22):5219-29. PubMed ID: 17069616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computer-based design of novel protein structures.
    Butterfoss GL; Kuhlman B
    Annu Rev Biophys Biomol Struct; 2006; 35():49-65. PubMed ID: 16689627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accurate prediction for atomic-level protein design and its application in diversifying the near-optimal sequence space.
    Fromer M; Yanover C
    Proteins; 2009 May; 75(3):682-705. PubMed ID: 19003998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoinhibition of X11/Mint scaffold proteins revealed by the closed conformation of the PDZ tandem.
    Long JF; Feng W; Wang R; Chan LN; Ip FC; Xia J; Ip NY; Zhang M
    Nat Struct Mol Biol; 2005 Aug; 12(8):722-8. PubMed ID: 16007100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of electrostatic interactions in PDZ domain ligand recognition.
    Harris BZ; Lau FW; Fujii N; Guy RK; Lim WA
    Biochemistry; 2003 Mar; 42(10):2797-805. PubMed ID: 12627945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An allosteric intramolecular PDZ-PDZ interaction modulates PTP-BL PDZ2 binding specificity.
    van den Berk LC; Landi E; Walma T; Vuister GW; Dente L; Hendriks WJ
    Biochemistry; 2007 Nov; 46(47):13629-37. PubMed ID: 17979300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of the proline-rich segment of myelin basic protein to SH3 domains: spectroscopic, microarray, and modeling studies of ligand conformation and effects of posttranslational modifications.
    Polverini E; Rangaraj G; Libich DS; Boggs JM; Harauz G
    Biochemistry; 2008 Jan; 47(1):267-82. PubMed ID: 18067320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining structure-based drug design and pharmacophores.
    Griffith R; Luu TT; Garner J; Keller PA
    J Mol Graph Model; 2005 Apr; 23(5):439-46. PubMed ID: 15781186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PDZ domain proteins: plug and play!
    Nourry C; Grant SG; Borg JP
    Sci STKE; 2003 Apr; 2003(179):RE7. PubMed ID: 12709532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Energetics of peptide recognition by the second PDZ domain of human protein tyrosine phosphatase 1E.
    Milev S; Bjelić S; Georgiev O; Jelesarov I
    Biochemistry; 2007 Jan; 46(4):1064-78. PubMed ID: 17240990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural insights into the PIP2 recognition by syntenin-1 PDZ domain.
    Sugi T; Oyama T; Morikawa K; Jingami H
    Biochem Biophys Res Commun; 2008 Feb; 366(2):373-8. PubMed ID: 18062914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutagenesis and selection of PDZ domains that bind new protein targets.
    Schneider S; Buchert M; Georgiev O; Catimel B; Halford M; Stacker SA; Baechi T; Moelling K; Hovens CM
    Nat Biotechnol; 1999 Feb; 17(2):170-5. PubMed ID: 10052354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of specificity and promiscuity of PDZ domain interactions through their dynamic behavior.
    Gerek ZN; Keskin O; Ozkan SB
    Proteins; 2009 Dec; 77(4):796-811. PubMed ID: 19585657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Random mutagenesis of PDZ(Omi) domain and selection of mutants that specifically bind the Myc proto-oncogene and induce apoptosis.
    Junqueira D; Cilenti L; Musumeci L; Sedivy JM; Zervos AS
    Oncogene; 2003 May; 22(18):2772-81. PubMed ID: 12743600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tandem PDZ repeats in glutamate receptor-interacting proteins have a novel mode of PDZ domain-mediated target binding.
    Feng W; Shi Y; Li M; Zhang M
    Nat Struct Biol; 2003 Nov; 10(11):972-8. PubMed ID: 14555997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of protein-ligand interaction fingerprints in docking.
    Brewerton SC
    Curr Opin Drug Discov Devel; 2008 May; 11(3):356-64. PubMed ID: 18428089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A hybrid clustering of protein binding sites.
    Iván G; Szabadka Z; Grolmusz V
    FEBS J; 2010 Mar; 277(6):1494-502. PubMed ID: 20148971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.